These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 18692341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.
    Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Kehagia V, Connett GJ, Bruce KD.
    J Clin Microbiol; 2006 Jul; 44(7):2601-4. PubMed ID: 16825392
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distinction between intact and antibiotic-inactivated bacteria by real-time PCR after treatment with propidium monoazide.
    Kobayashi H, Oethinger M, Tuohy MJ, Hall GS, Bauer TW.
    J Orthop Res; 2010 Sep; 28(9):1245-51. PubMed ID: 20186836
    [Abstract] [Full Text] [Related]

  • 6. The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples.
    Rogers GB, Marsh P, Stressmann AF, Allen CE, Daniels TV, Carroll MP, Bruce KD.
    Clin Microbiol Infect; 2010 Nov; 16(11):1656-8. PubMed ID: 20148918
    [Abstract] [Full Text] [Related]

  • 7. Molecular monitoring of disinfection efficacy using propidium monoazide in combination with quantitative PCR.
    Nocker A, Sossa KE, Camper AK.
    J Microbiol Methods; 2007 Aug; 70(2):252-60. PubMed ID: 17544161
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the bacterial microbiome in first-pass meconium using propidium monoazide (PMA) to exclude nonviable bacterial DNA.
    Stinson LF, Keelan JA, Payne MS.
    Lett Appl Microbiol; 2019 May; 68(5):378-385. PubMed ID: 30674082
    [Abstract] [Full Text] [Related]

  • 9. Selective detection of live bacteria combining propidium monoazide sample treatment with microarray technology.
    Nocker A, Mazza A, Masson L, Camper AK, Brousseau R.
    J Microbiol Methods; 2009 Mar; 76(3):253-61. PubMed ID: 19103234
    [Abstract] [Full Text] [Related]

  • 10. Selective detection of viable Helicobacter pylori using ethidium monoazide or propidium monoazide in combination with real-time polymerase chain reaction.
    Nam S, Kwon S, Kim MJ, Chae JC, Jae Maeng P, Park JG, Lee GC.
    Microbiol Immunol; 2011 Dec; 55(12):841-6. PubMed ID: 22004535
    [Abstract] [Full Text] [Related]

  • 11. Unsuitable distinction between viable and dead Staphylococcus aureus and Staphylococcus epidermidis by ethidium bromide monoazide.
    Kobayashi H, Oethinger M, Tuohy MJ, Hall GS, Bauer TW.
    Lett Appl Microbiol; 2009 May; 48(5):633-8. PubMed ID: 19416465
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the microbiota of sputum samples from patients with lower respiratory tract infections.
    Zhou Y, Lin P, Li Q, Han L, Zheng H, Wei Y, Cui Z, Ni Y, Guo X.
    Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):754-61. PubMed ID: 20823075
    [Abstract] [Full Text] [Related]

  • 13. Fluorescent amplified fragment length polymorphism (FAFLP) based molecular epidemiology of hospital infections in a tertiary care setting in Hyderabad, India.
    Kenchappa P, Rao KR, Ahmed N, Joshi S, Ghousunnissa S, Vijayalakshmi V, Murthy KJ.
    Infect Genet Evol; 2006 May; 6(3):220-7. PubMed ID: 16054876
    [Abstract] [Full Text] [Related]

  • 14. Quantifying fungal viability in air and water samples using quantitative PCR after treatment with propidium monoazide (PMA).
    Vesper S, McKinstry C, Hartmann C, Neace M, Yoder S, Vesper A.
    J Microbiol Methods; 2008 Feb; 72(2):180-4. PubMed ID: 18160156
    [Abstract] [Full Text] [Related]

  • 15. Comparison of ethidium monoazide and propidium monoazide for the selective detection of viable Legionella cells.
    Chang B, Taguri T, Sugiyama K, Amemura-Maekawa J, Kura F, Watanabe H.
    Jpn J Infect Dis; 2010 Mar; 63(2):119-23. PubMed ID: 20332575
    [Abstract] [Full Text] [Related]

  • 16. Use of propidium monoazide and increased amplicon length reduce false-positive signals in quantitative PCR for bioburden analysis.
    Schnetzinger F, Pan Y, Nocker A.
    Appl Microbiol Biotechnol; 2013 Mar; 97(5):2153-62. PubMed ID: 23354451
    [Abstract] [Full Text] [Related]

  • 17. Use of propidium monoazide and quantitative PCR for differentiation of viable Escherichia coli from E. coli killed by mild or pasteurizing heat treatments.
    Yang X, Badoni M, Gill CO.
    Food Microbiol; 2011 Dec; 28(8):1478-82. PubMed ID: 21925032
    [Abstract] [Full Text] [Related]

  • 18. Sodium chloride affects propidium monoazide action to distinguish viable cells.
    Barth VC, Cattani F, Ferreira CA, de Oliveira SD.
    Anal Biochem; 2012 Sep 15; 428(2):108-10. PubMed ID: 22728959
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
    Spasenovski T, Carroll MP, Payne MS, Bruce KD.
    Diagn Microbiol Infect Dis; 2009 Mar 15; 63(3):261-7. PubMed ID: 19216939
    [Abstract] [Full Text] [Related]

  • 20. Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
    Nguyen LD, Deschaght P, Merlin S, Loywick A, Audebert C, Van Daele S, Viscogliosi E, Vaneechoutte M, Delhaes L.
    PLoS One; 2016 Mar 15; 11(12):e0168860. PubMed ID: 28030619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.